On March 17, 2025, the Office of the Comptroller of the Currency (OCC) announced that it conditionally approved a fintech business model for CenTrust Bank, N.A.’s (“CenTrust”), an Illinois based community bank chartered by the OCC.[1] CenTrust was acquired by SmartBiz Loans, which is a fintech company that provides an online platform to connect small business owners with lenders providing Small Business Administration (“SBA”) loans. Following the acquisition, CenTrust applied to change its business model to incorporate the SmartBiz Loans’ business model of providing SBA loans nationwide.

Revelstoke Capital Partners has announced a recapitalization of AOM Infusion.

AOM, founded in 1994 and based in Fort Worth, Texas, is a specialty infusion provider focused on chronic therapy management.

Revelstoke, founded in 2013 and based in Denver, focuses on investing in the healthcare and related business services sectors. The firm typically commits

On April 15, 2025, the Trump Administration issued an Executive Order titled “Restoring Common Sense to Federal Procurement” that seeks to reform the Federal Acquisition Regulation (“FAR”) and agency-specific supplements to contain only those “provisions required by statute or essential to sound procurement.”  Along with a supplemental fact sheet, the Executive Order states that “any FAR provisions that do not advance these objectives should be removed.”  This overhaul of the FAR has been widely anticipated during the first few months of the Trump Administration, although its implementation is expected to be a multi-year process.

Max Reiboldt visits McGuireWoods partner and host Geoff Cockrell about the future of private equity in healthcare, particularly in provider services. Chairman of the Coker Group, a leading sell-side investment bank in healthcare transactions, Max is the lead author of “Private Equity in Healthcare, Leadership Economics and Trends for the Future.”

Tune in

In a significant move signaling Europe’s growing autonomy in global anti-corruption enforcement, prosecutors from the United Kingdom, France, and Switzerland have formed a new cross-border alliance: the International Anti-Corruption Prosecutorial Taskforce. Announced on March 20, 2025 by the U.K.’s Serious Fraud Office (SFO), the taskforce is designed to deepen cooperation among these three countries on bribery and corruption investigations—at a time when the Trump Administration is reshaping the United States’ approach.

Clearview Capital has announced the recapitalization of Advantage Behavioral Health.

Advantage, founded in 2017 and based in Laurel Springs, New Jersey, is mental health treatment provider operating in nine states. The company is focused on outpatient programs across various levels of care, delivering both in-person and telehealth services.

Clearview, founded in 1999 and

New Mountain Capital has completed a growth investment in Office Ally, according to a news release.

Office Ally, founded in 2000 and based in Vancouver, Washington, is a healthcare technology company that offers cloud-based solutions for healthcare providers, partners and payers.

New Mountain, based in New York, is a growth-oriented investment firm.

A first appellate circuit judge has questioned the False Claim Act’s constitutionality.  In the Fifth Circuit’s decision last month in United States ex rel Montcrief v. Peripheral Vascular Assocs., P.A., No. 24-50176, — F. 4th –, 2025 WL 939890 (5th Cir. Mar. 28, 2025), Judge Stuart Kyle Duncan separately wrote a concurring opinion to express skepticism regarding the constitutionality of the qui tam provision of the False Claims Act.  Adding to a decision issued by a Florida federal district court last fall, Judge Duncan said that the qui tam provision of the False Claims Act violates the Appointments Clause of the Constitution because it allows private citizens to exercise the power of the executive branch despite not being appointed or confirmed as an officer of the United States. 

McGuireWoods partner and host Geoff Cockrell, invites Matt Stekier, a principal at Plante Moran’s management consulting group, to discuss challenges in the medical devices and product sector. 

Matt covers supply chain vulnerabilities, inventory management issues and post-acquisition integration. He explains how Plante Moran helps clients identify and mitigate these challenges, including through